| Hans-Günter Meyer-Thompson | Verschiedenes
Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity.
Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity.
Mansoori A, Bazrafshan A, Ahmadi J, Mosavat SH.
Trials. 2025 Apr 17;26(1):133. doi: 10.1186/s13063-025-08836-4. PMID: 40247293; PMCID: PMC12004569.